(Q40995176)

25 September 2017

Host-directed drug therapy for tuberculosis (English)

1 reference

25 September 2017

1 reference

Reto Guler

1

1 reference

PubMed ID

26379013

25 September 2017

Frank Brombacher

series ordinal

2

1 reference

25 September 2017

1 September 2015

1 reference

25 September 2017

Nature Chemical Biology

1 reference

25 September 2017

11

1 reference

25 September 2017

10

1 reference

25 September 2017

748-751

1 reference

https://scigraph.springernature.com/pub.10.1038/nchembio.1917

25 September 2017

0 references

cites work

The interaction of mycobacterial protein Rv2966c with host chromatin is mediated through non-CpG methylation and histone H3/H4 binding

1 reference

12 December 2020

Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7

1 reference

12 December 2020

The two-domain LysX protein of Mycobacterium tuberculosis is required for production of lysinylated phosphatidylglycerol and resistance to cationic antimicrobial peptides

1 reference

12 December 2020

Metformin as adjunct antituberculosis therapy

1 reference

12 December 2020

A promoter-level mammalian expression atlas

1 reference

12 December 2020

Statin therapy reduces the mycobacterium tuberculosis burden in human macrophages and in mice by enhancing autophagy and phagosome maturation.

1 reference

12 December 2020

Host-directed therapy of tuberculosis: what is in it for microRNA?

1 reference

12 December 2020

Simvastatin enhances protection against Listeria monocytogenes infection in mice by counteracting Listeria-induced phagosomal escape

1 reference

12 December 2020

ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria

1 reference

12 December 2020

Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells

1 reference

12 December 2020

Non-coding RNAs and HIV: viral manipulation of host dark matter to shape the cellular environment.

1 reference

12 December 2020

Mycobacterium tuberculosis Mce3E suppresses host innate immune responses by targeting ERK1/2 signaling

1 reference

12 December 2020

New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics

1 reference

12 December 2020

Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis

1 reference

12 December 2020

Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence

1 reference

12 December 2020

Essential role for cholesterol in entry of mycobacteria into macrophages

1 reference

12 December 2020

Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst

1 reference

12 December 2020

Advancing host-directed therapy for tuberculosis

1 reference

12 December 2020

Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling

1 reference

12 December 2020

The effect of statins on mortality in patients with bacteremia

1 reference

12 December 2020

Long noncoding RNAs: a potent source of regulation in immunity and disease

1 reference

12 December 2020

Mycobacterium tuberculosis suppresses innate immunity by coopting the host ubiquitin system

1 reference

12 December 2020

Redefining the transcriptional regulatory dynamics of classically and alternatively activated macrophages by deepCAGE transcriptomics.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCHEMBIO.1917

1 reference

PubMed ID

26379013

Dimensions Publication ID

25 September 2017

0 references

1 reference

PubMed ID

26379013